Two Jacobs School of Medicine and Biomedical Sciences’ researchers studying how to develop novel, non-addicting painkillers have each been issued awards by the Helping to End Addiction Long-term (HEAL) Initiative, a prestigious and highly competitive program from the National Institutes of Health.
An innovative researcher and others who have made significant contributions to their fields and to the Jacobs School of Medicine and Biomedical Sciences were honored with 2019 Faculty-Staff Recognition Awards.
Jun-Xu Li, MD, PhD, has been awarded a five-year, $2 million National Institutes of Health grant to investigate a novel therapy that may prove more powerful than currently available smoking cessation treatments.
The Jacobs School of Medicine and Biomedical Sciences and UB’s Clinical and Research Institute on Addictions (CRIA) played host to a prestigious Fulbright Enrichment Seminar on the opioid epidemic that brought 79 Fulbright Foreign Students from 51 countries to downtown Buffalo.
The PhD Program in Biomedical Sciences (PPBS) conducted its third annual white coat ceremony to recognize 19 students from the Class of 2018-2019 — 14 doctoral students and five MD-PhD students — who completed their first year in the program and are moving on to their research laboratory match.